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ABSTRACT 
Objective: The aim of this study is to describe and evaluate the feasibility of an expanded transcanal 
transpromontorial approach, developed from the exclusive endoscopic transcanal transpromontorial 
approach.  
Study Design: Retrospective case series. 
Methods: Retrospective chart review of 10 patients operated by an expanded transcanal 
transpromontorial approach in two tertiary referral centers (University Hospital of Modena and 
University Hospital of Verona, Italy). Data from charts and video documentation were collected and 
analyzed. 
Results: Between April 2015 and January 2016, 10 patients underwent an expanded transcanal 
transpromontorial approach for vestibular schwannoma Koos Stage I or II and were enrolled in the 
study. The size of the tumors ranged from 7 to 19 millimeters in maximum diameter. A gross total 
resection was achieved in all cases. One subject experienced postoperative CSF otorhinorrhea and 
three subjects experiences temporary postoperative facial weakness all of which resolved. The mean 
follow-up was 5 months. 
Conclusion: The expanded transcanal transpromontorial approach allowed bimanual dissection 
using a microscopic technique for the treatment of pathologies of the internal auditory canal and 
cerebellopontine angle. This novel approach resulted in minimal morbidity and comparable facial 
 
 3 
nerve preservation rates to the traditional approaches to the internal auditory canal. The expanded 
transpromontorial approach to the internal auditory canal holds promise for addressing pathology in 
this region of the temporal bone from the external auditory canal. 
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The classical surgical corridors to the internal auditory canal (IAC) and the cerebellopontine angle 
(CPA) are indirect approaches. In the retrosigmoid and transmastoid-translabyrinthine approach the 
pathology is reached posteriorly, while the middle cranial fossa approach gains access to the IAC 
superiorly. The advantages, disadvantages, clinical indications, morbidity and mortality have been 
carefully described1 and therefore, these approaches are routinely used. However, the retrosigmoid 
and the middle cranial fossa approach require a craniotomy and the transmastoid-translabyrinthine 
depends on a subtotal petrosectomy to access the pathology.1 Moreover, the retrosigmoid approach 
needs intradural drilling of the posterior aspect of the petrous bone to reach the pathology at the 
fundus of the IAC. In order to minimize the drilling of the posterior bony lining of the IAC, the 
endoscope was introduced two decades ago. After conventional access to the CPA, the endoscope 
was used to gain access and enhance visibility at the fundus of the IAC.2  
In the same aim endoscopic techniques were introduced to visualize middle ear pathology during its 
surgical treatment since the 1990s.3 In a first phase the endoscope was used during conventional 
microscopic operations to assist the surgeon in the exploration of hidden recesses due to the wide 
angle view and the possibility to use angulated scopes.4 With growing experience the endoscopic 
technique was used as the main tool in the surgical treatment of middle ear cholesteatoma, using the 
microscope complimentary in case of mastoid involvement of the pathology.5,6 Technical and 
surgical refinements allowed to introduce the advantages of the endoscopic middle ear surgery in 
novel endoscopic approaches to the lateral skull base.7,8 
With ongoing investigations, the authors developed techniques to directly access the inner ear 
through the external auditory canal (EAC), either choosing an endoscopic assisted microscopic or 
even an exclusive endoscopic technique. These advances in developing a novel surgical technique 
required thorough understanding of the anatomy and identification of appropriate instruments, 
which was achieved during several cadaver dissections, prior to a clinical application.9  
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The first clinical implication of the exclusive endoscopic approach to the IAC was realized in 
March 2012. For the first time a cochlear schwannoma (CS) involving the IAC was removed using 
a direct transpromontorial approach through the external to the internal auditory canal, without any 
external incision.10 Other lateral skull base applications have been described by our team during the 
last 2 years.7.8 The first case series using an exclusive endoscopic transcanal transpromontorial 
approach (EndoTTA) to remove vestibular schwannomas (VS) involving the IAC has recently been 
published.11 However, the treatment of Koos I VS is still a matter of debate,12 in selected cases a 
new surgical approach may offer a valuable alternative. 
The transpromontorial removal of larger tumors (Koos II) with limited extension to the CPA would 
require bimanual dissection of the tumor and intracranial vessels. The straight and direct access to 
the IAC as described by the EndoTTA may also be promising for a microscopic approach. 
However, the implementation of a microscope based transpromontorial technique requires an 
enlarged access route in order to enhance visibility and the surgical freedom. The aim of this study 
is to describe an expanded transcanal transpromontorial approach (ExpTTA) and report its 
feasibility in the first case series.  
 
MATERIALS AND METHODS 
Between January and February 2016, a retrospective chart review was carried out on patients 
operated by ExpTTA from March 2015 to January 2016. Data were gathered and summarized for 
further consideration based on charts, images, videos and surgical reports. 
The ExpTTA was indicated in the following cases: 
- Growing mass, evaluated during follow-up using magnetic resonance imaging (MRI),  tumor 
growth was defined as an increase in tumor size in two consecutive MRI studies; 
- Koos Stage I (mass located in the IAC) or Koos Stage II (IAC involvement and limited extension 
to the CPA); 
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- Patients with severe to profound hearing loss (evaluated with pure tone average (PTA) and speech 
recognition threshold (SRT) at speech audiometry) and/or patients with severe vertigo and 
concomitant pronounced neurovegetative symptoms such as nausea and vomiting. 
All patients were operated by two senior otolaryngologists (DM and LP) in cooperation with senior 
neurosurgeons. Before implication in patients, the ExpTTA was studied on cadavers in order to 
determine suitable instruments and to identify the important surgical landmarks as described next. 
 
Approach to the tympanic cavity and identification of the main landmarks (Figures 1 and 2) 
The patient lay in the supine position with head slightly extended and rotated to the contralateral 
side. Intraoperative facial nerve monitoring was mandatory. The surgeon used principally a 
standard otological microscope and complimentary, when required a 4 mm diameter, 15 cm length, 
0° angled endoscope (Karl Storz, Tuttlingen, Germany). The endoscope and the microscope were 
connected to an AIDA three-chip high-resolution monitor and camera system (Karl Storz, 
Tuttlingen, Germany). All operations were recorded and stored in a digital archive for 
documentation and further analyses. 
First, the endoscope was introduced through the EAC and a circular incision of the EAC skin was 
made approximately 1.5 cm from the tympanic annulus. After dissection of a circular tympano-
meatal flap, the skin was removed en block with the tympanic membrane. A Shambaugh incision 
(intercartilaginous incision between helix and tragus) was performed in order to expose the lateral 
portion of the EAC bone. 
After positioning orthostatic retractors, the EAC was drilled circumferentially under microscopic 
view to widen the surgical field so as to achieve an adequate view and movement of the surgical 
instruments in the EAC. Drilling of the EAC was continued until the temporo-mandibular joint 
capsule was exposed, an important anatomical landmark representing the superficial anterior limit. 
A wide atticotomy was performed to expose the ossicular chain. The incus and malleus were 
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removed to obtain a clear view of the whole tympanic tract of the facial nerve, the geniculate 
ganglion and its relationship with the cochleariform process. 
Identification of the important landmarks for this approach continued with exposure of the middle 
cranial fossa dura superiorly (by removing the tympanic tegmen), the carotid artery anteriorly 
below the tympanic tube orifice (in the protympanic space), the jugular bulb inferiorly, and the third 
tract of the facial nerve posteriorly. 
 
Transpromontorial approach to the IAC (Figures 3 and 4) 
As a result of the enlarged EAC as described above, bimanual dissection under microscopic view 
was easily possible for the following steps. After careful identification of the anatomical landmarks, 
the surgery proceeded with removal of the stapes from the oval window and exposure of the 
vestibule and spherical recess in the saccular fossa. This structure looks like a thin cribriform plate 
separating the vestibule from the fundus of the IAC and represents the site of medial termination of 
the inferior vestibular nerve fibers. The oval window was enlarged using a microcurette, a burr or 
by Piezosurgery instrument (Mectron, Carasco/Genova, Italy). Thereafter, we adopted a 
transpromontorial approach to the IAC, removing the promontorial bone and progressively 
exposing the basal, middle and apical turn of the cochlea. 
Knowledge of the position of the labyrinthine tract of the facial nerve was determined from the 
previously identified anatomical landmarks, serving as boundaries to the surgical field. An 
imaginary line from the geniculate ganglion to the spherical recess passing just above the apical 
turn of the cochlea indicated the route of the facial nerve into the inner ear. 
The dura of the IAC was progressively exposed inferiorly and posteriorly from the fundus to the 
porus of the IAC until reaching the reflection of the dura on the petrous bone. At this point, our 
limits of dissection were the second tract of the facial nerve superiorly, the vertical tract of the 
internal carotid artery anteriorly, the jugular bulb inferiorly, the third portion of the facial nerve 
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posteriorly, and the middle cranial fossa dura superiorly. The dura along the IAC was then opened 
to reach the tumor. 
Removal of the pathology was performed from the meatus to the fundus of the IAC using a 
“piecemeal” technique until a radical removal was obtained. The neoplasm was carefully dissected 
using traditional microscissors or appropriate elevators. Ultrasound suction was not used because of 
the lack of room for maneuver with the keyhole approach. Because of the relatively small 
dimensions of the neoplasm, we believe that conventional instruments are sufficient for dissection 
of tumors from the facial nerve. 
The extension of the neoplasm to the CPA was removed with further bone drilling to enlarge the 
opening of the IAC meatus, always keeping in mind the anatomical boundaries of the dissection to 
avoid damage to noble structures, and following the acoustic-facial bundle towards the entry zone. 
At the end of tumor excision, the endoscope allowed us to check for complete tumor removal and to 
gain a wider view of the vascular and nervous structures. Finally, facial nerve function was checked 
with the intraoperative facial nerve monitoring system. 
The transpromontorial defect created was closed with a fat pad harvested from the abdomen and 
positioned between the inner and middle ear. Thereafter, the graft was covered by fibrin glue. The 
Eustachian tube was closed with muscle fragments and bone dust to avoid abdominal fat resorption 
caused by airflow from the rhinopharynx. The final step was cul-de-sac closure of the residual skin 
of the EAC. 
 
RESULTS 
Between April 2015 and January 2016, 10 patients underwent the expanded transcanal 
transpromontorial approach (ExpTTA) for VS at the Otolaryngology Department of the University 
Hospital of Modena or at the Otolaryngology Department of the University Hospital of Verona and 




Preoperative assessment (Table 1) 
The mean age of our cohort was 53.6 years and the male/female ratio was 3:7. All patients suffered 
from subjective hearing loss, associated with vertigo in five cases. In addition, one patient presented 
a hemifacial spasm. 
As regards tumor size, the mean diameter of maximum extent was 12.21 mm (range 7 to 19 mm). 
Koos classification was used to evaluate the growth pattern of the VS. We staged two cases as Koos 
Stage I and eight cases as Koos Stage II. 
Preoperative hearing was classified using PTA threshold and threshold of perception at speech 
audiometry. Mean PTA was 66 dB HL. In four subjects, the degree of hearing loss at PTA was 
moderate but they presented severe vertigo with associated neurovegetative symptoms. The mean 
SRT was 65.8 dB, with a range from 45 dB to 100 dB. These results were calculated on 6 of the 10 
patients in our casuistry, because 4 patients didn’t reach this threshold. 
 
Surgical procedures 
All 10 ExpTTAs allowed us to remove the VS radically. No intraoperative complications were 
reported. The average length of surgery was 250 minutes. In all cases, an abdominal fat graft was 
used to close the transpromontorial defect and a cul-de-sac closure of the external ear canal. In eight 
cases, a watertight closure of the Eustachian tube was performed using either abdominal fat (n=2) 
or muscle fragments and bone dust (n=6). In two cases no closure of the Eustachian tube was 
performed. Since this procedure involves removal of the cochlea, ipsilateral deafness was present 
after surgery in all patients. The final histologic exam identified VS in all the specimens. 
 
Postoperative assessment (Table 2) 
Four patients were admitted postoperatively to the intensive care unit (ICU) for 24–48 hours, this as 
a safety measure with regard to comorbidities. In six cases, the patients were immediately extubated 
at the end of the procedure and monitored at the inpatient clinic. A postoperative CT scan was 
 
 10 
obtained in all patients showing no complications. The mean hospital stay after ExpTTA was 7.5 
days (range: 6 to 10 days). No patient required prolonged treatment of vertigo or vestibular 
rehabilitation after the surgical intervention. The mean follow-up was 5 months. 
One patient presented with postoperative CSF otorhinorrhea requiring a surgical revision. During 
the second surgical procedure, we noticed a complete reabsorption of the abdominal fat graft. The 
adipose tissue was removed from the temporal bone, and a graft harvested from the temporal 
muscle was used to repair the defect. 
 
Facial nerve outcome 
Intraoperative facial nerve monitoring was always used to detect facial nerve function during 
identification and removal of the neoplasm. All the patients in this study had a grade 1 (normal) 
preoperative facial nerve function, evaluated with the House-Brackmann grading system.13 
Immediately after surgery, 3/10 patients (30%) presented a transitory facial palsy grade II with 
complete recovery during the follow-up period in all cases. The remaining 7/10 (70%) patients had 
a normal facial nerve function immediately after surgery up to the last follow-up evaluation. 
 
DISCUSSION 
The IAC is an anatomical region, which is relatively difficult to access. Outcomes and associated 
complications of the various approaches with regard to VS surgery are reported in the literature.14 
These data comparisons indicate that the middle cranial fossa approach is superior to the 
retrosigmoid approach for hearing preservation in patients with tumors <1.5 cm.  
As regards postoperative facial nerve dysfunction (House-Brackmann grade III or higher) the 
results are largely dependent on tumor size, as identified by a large systematic review including 
more than 5000 patients.14 Comparing the different approaches the retrosigmoid technique is 
associated with significantly better results in patients with intracanalicular tumors than the middle 
cranial fossa technique (4% vs 16.7%, respectively).14 These results were confirmed by Yamakami 
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et al. who observed no residual facial palsy at last follow up in a cohort of 44 patients undergoing a 
retrosigmoid approach.15 For patients with tumors < 1.5 cm, the middle cranial fossa procedure is 
associated with significantly better results with regard to facial nerve dysfunction compared with 
the translabyrinthine approach (3.3% vs 11.5%, respectively), and the retrosigmoid approach is the 
best approach in terms of saving facial nerve function for tumors 1.5–3.0 cm.14 However, another 
large study on 1151 reported the middle cranial fossa approach to account for the highest 
percentage of postoperative facial palsy grade III or higher (32.4%) when compared to the 
translabyrinthine (13.9%) or retrosigmoid (3.1%) in tumors < 1cm.16 The retrosigmoid approach is 
also superior to the translabyrinthine approach for tumors > 3.0 cm (30.2% vs 42.5%, 
respectively).14 In our study including Koos Grade I and II VS, we noted the absence of facial nerve 
dysfunction in all patients at last follow-up. However it is extremely difficult to compare the 
different reports in literature as the surgical experience, the indications to surgery and even the 
method to assess tumor size16 very considerably in literature.  
Another important postoperative complication during VS surgery is CSF leakage. The incidence of 
CSF leakage in the literature is significantly greater after the retrosigmoid approach than after either 
the middle cranial fossa or translabyrinthine approaches (10.3%, 5.3%, 7.1%, respectively).14 In our 
study, we observed one case of oto-rhinoliquorrhea due to abdominal fat graft resorption, with 
complete recovery of CSF leakage after revision surgery. Reported operative mortality rates for 
middle cranial fossa, retrosigmoid, and translabyrinthine approaches are 0%, 0.3% and 1.3%, 
respectively.14 Concerning major neurological complications, the different rates reported in the 
literature for middle cranial fossa surgery, retrosigmoid approach and translabyrinthine procedure 
are 2.4%, 1.8% and 2.6%, respectively.14 Of course, it is very difficult to compare those rates using 
classical approaches to our results because 10 patients is a very small number from which to draw 
conclusions. However, the authors believe that the promising results in terms of morbidity, 
complications and postoperative recovery in our study will be confirmed in larger case series. 
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Due to the reported intraoperative complications and resulting postoperative morbidity, in most 
cases a wait-and-scan policy is adopted for VS17. However, an alternative includes radiosurgical 
management of VS. Adequate control of VS by radiosurgery has been documented.18 Nevertheless, 
no long-term results or studies which prospectively compare wait-and-scan policy to radiosurgery 
are available. At present, we do not know exactly what percentage of growth is stopped by 
radiosurgery and what percentage would have stopped anyway in their natural history, as often 
occurs. We have to consider that in a young patient, the choice of radiosurgery cannot exclude a 
possible reoperation in the future, with a higher risk of complications. 
This study presents the first case series of patients operated by an ExpTTA for VS treatment. Since 
the first clinical application in 201310 the transpromontorial access was successfully used to treat 
Koos Stage I and II VS by the EndoTTA12. The endoscopic technique offers high magnification of 
every structure inside and outside the IAC, including the facial nerve. This straight 
transpromontorial access is now enriched by the present extended approach, which allows bimanual 
dissection and therefore enhanced control of the tumor and neurovascular structures. In fact, the 
endoscopic steps are also important in the ExpTTA, for example, in precise drilling of the cochlea, 
or during identification of the intralabyrinthine portion of the facial nerve.  
Despite strict indications for VS surgery, we consider that the ExpTTA is a promising and 
innovative approach. The direct transpromontorial access allows complete removal of the pathology 
with a very low morbidity. Indications for EndoTTA and ExpTTA will probably be subject to 
modification in future, since they are very new techniques and improvements are still being made. 
At present, we would recommend an EndoTTA in the case of tumors less than 1 cm, involving the 
most lateral portion of the IAC. In the case of tumors of larger dimensions, exceeding 1 cm or 
involving the CPA, we would recommend an ExpTTA.  
Concerning surgical morbidity, we have to consider that, in part, our favorable results regarding the 
FN are possibly due to the early stage of the VS. These tumors are less adherent to the FN inside the 
IAC. In our opinion, access to the intradural compartment through the EAC should not influence the 
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risk of infection, since, in most cases, the middle ear is a sterile cavity. No infections of the surgical 
site or meningitis have been reported in the present case series or in EndoTTA approaches.12 
Needless to say, that hearing preservation is not feasible with this approach. Due to the removal of 
the cochlea a concomitant ipsilateral cochlear implantation is not possible. For this reason, the 
indication must include only patients with poor hearing. However, in our experience it is technically 
challenging to preserve the cochlear nerve when removing tumors involving the fundus of the IAC. 
We wish to emphasize that in this case series, four patients were monitored postoperatively in the 
ICU as a precautionary measure. They did not present any complications in the immediate 
postoperative period. Six patients were directly extubated and sent to the inpatient clinic, just as 
happens in middle ear surgery. Mean hospital stay was approximately 7 days and the operative time 
was also quite short (approximately 250 minutes). Although the length of postoperative stay could 
be compared to a classical retrosigmoid or translabyrinthine approach, a further shortening of 
surgical times and postoperative hospital stay may be expected in the future, since, in most cases, 
special caution was taken due to the novelty of the technique. 
In summary, the ExpTTA can be considered to be a sort of less-invasive translabyrinthine approach, 
since it removes the cochlea, but spares the mastoid and most of the temporal bone and avoids large 
skin incisions and wide soft tissue dissections. Of course, further clinical experience is necessary to 
confirm the potential benefits, feasibility and morbidity of this expanded approach. The risks of the 
approach must also be underlined: in fact, working medially towards the CPA, the risk of 
uncontrollable bleeding, possibly from branches of the antero-inferior cerebellar artery (AICA) 
would increase and the space created may not be large enough to control it. The bleeding concern is 
particularly true for the largest neoplasms, and for the most medial ones. In fact, in our experience 
with both EndoTTA and ExpTTA, the smaller masses do not have close relationships with relevant 
vessels, and they are only sparsely vascularized. We must emphasize that, in the case of 
uncontrollable bleeding which could not be managed through the EAC, a shift to a retrosigmoid 
approach would be facilitated by the low intracranial pressure (CSF already drained by the TTA). 
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Finally, every kind of endoscopic lateral skull base procedure requires a preliminary long training 
period in endoscopic middle ear surgery to acquire sufficient manual expertise. In addition, 
excellent knowledge of endoscopic landmarks is necessary, to recognize and dissect neurovascular 
structures inside the temporal bone in the safest manner. 
 
CONCLUSION 
The ExpTTA proved to be successful as a transpromontorial access to the IAC allowing a 
microscopic technique and therefore bimanual dissection. In the presented case series, we observe 
successful tumor removal from the cochlea, the fundus of the IAC and the most lateral portion of 
the CPA with low complication rates. The described approach appears to be safe and less invasive 
compared to traditional microscopic procedures.  
 
ACKNOWLEDGMENTS 
LA acknowledges the research fellowship from the Bangerter-Rhyner Foundation, Bern, 
Switzerland and from Karl Storz GmbH, Tuttlingen, Germany. The funders played no role in study 














1. Bennett M, Haynes DS. Surgical approaches and complications in the removal of vestibular 
schwannomas. Otolaryngol Clin North Am 2007 Jun;40(3):589–609. 
2. Magnan J, Chays A, Lepetre C, Pencroffi E, Locatelli P. Surgical perspectives of endoscopy 
of the cerebellopontine angle. Am J Otol 1994 May;15(3):366–370. 
3. Thomassin JM, Korchia D, Doris JM. Endoscopic guided otosurgery in the prevention of 
residual cholesteatomas. Laryngoscope 1993;103:939–943. 
4. Presutti L, Marchioni D, Mattioli F, Villari D, Alicandri-Ciufelli M. Endoscopic 
management of acquired cholesteatoma: our experience. J Otolaryngol Head Neck Surg 
2008 Aug;37(4):481–487. 
5. Marchioni D, Alicandri-Ciufelli M, Molteni G, Genovese E, Presutti L. Endoscopic 
tympanoplasty in patients with attic retraction pockets. Laryngoscope 2010 
Sep;120(9):1847–1855. 
6. Tarabichi M. Endoscopic management of limited attic cholesteatoma. Laryngoscope 2004 
Jul;114(7):1157–1162. 
7. Marchioni D, Alicandri-Ciufelli M, Rubini A, Presutti L. Endoscopic transcanal corridors to 
the lateral skull base: Initial experiences. Laryngoscope 2015 Sep;125 Suppl 5:S1–S13. 
8. Presutti L, Nogueira JF, Alicandri-Ciufelli M, Marchioni D. Beyond the middle ear: 
endoscopic surgical anatomy and approaches to inner ear and lateral skull base. Otolaryngol 
Clin North Am 2013 Apr;46(2):189–200. 
9. Marchioni D, Alicandri-Ciufelli M, Mattioli F, et al. From external to internal auditory 
canal: surgical anatomy by an exclusive endoscopic approach. Eur Arch Otorhinolaryngol 
2013 Mar;270(4):1267–1275. 
10. Presutti L, Alicandri-Ciufelli M, Cigarini E, Marchioni D. Cochlear schwannoma removed 
through the external auditory canal by a transcanal exclusive endoscopic technique. 
Laryngoscope 2013 Nov;123(11):2862–2867. 
 
 16 
11. Thakur JD, Banerjee AD, Khan IS, et al. An update on unilateral sporadic small vestibular 
schwannoma. Neurosurg Focus 2012 Sep;33(3):E1 
12. Marchioni D, Alicandri-Ciufelli M, Rubini A, Masotto B, Pavesi G, Presutti L. Exclusive 
endoscopic transcanal transpromontorial approach: a new perspective for internal auditory 
canal vestibular schwannoma treatment. J Neurosurg 2016 Mar;11:1–8. 
13. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 
93:146–147, 1985  
14. Ansari SF, Terry C, Cohen-Gadol AA. Surgery for vestibular schwannomas: a systematic 
review of complications by approach. Neurosurg Focus 2012 Sep;33(3):E14. 
15. Yamakami I, Ito S, Higuchi Y. Retrosigmoid removal of small acoustic neuroma: curative 
tumor removal with preservation of function. J Neurosurg. 2014 Sep;121(3):554-63.  
16. Falcioni M, Fois P, Taibah A, Sanna M. Facial nerve function after vestibular schwannoma 
surgery. J Neurosurg. 2011 Oct;115(4):820-6.  
17. Patnaik U, Prasad SC, Tutar H, Giannuzzi AL, Russo A, Sanna M. The long-term outcomes 
of wait-and-scan and the role of radiotherapy in the management of vestibular 
schwannomas. Otol Neurotol 2015 Apr;36(4):638–646. 
18. Jacob JT, Pollock BE, Carlson ML, Driscoll CL, Link MJ. Stereotactic radiosurgery in the 
management of vestibular schwannoma and glomus jugulare: indications, techniques, and 












Figure 1: Right ear. External view of the access after incision and superficial soft tissue dissection. 
 
Figure 2: Right ear. Panel A: endoscopic view. Circumferential incision of the skin of the external 
auditory canal (EAC). Panel B: microscopic view. Shambaugh incision and superficial soft tissue 
displacement to widely access the bony EAC. Panel C: endoscopic view. Tympanic cavity 
exploration after calibration of the EAC. Panel D, endoscopic view. Ossicular chain removal. 
tm: tympanic membrane, eac: external auditory canal, ma: malleus, in: incus, st: stapes. 
 
Figure 3: Right ear. Panel A: endoscopic view. Promontory drilling and exposure of the cochlea. 
Panel B: microscopic view. Drilling of the internal auditory canal (IAC) to expose the vestibular 
schwannoma (VS). Arrow indicates direction and extent of drilling. Panel C: microscopic view. 
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Tumor dissection from nerves and vessels. Panel D: microscopic view. AICA and facial nerve are 
dissected from the pathology. 
co: cochlea, pr: promontory, vs: vestibular schwannoma, aica: antero-inferior cerebellar artery, fn: 
facial nerve 
 
Figure 4: Right ear. Panel A: microscopic view after tumor removal (low magnification). Panel B 
and C: endoscopic view after tumor removal. Panel D: endoscopic view. Exploration of the CPA. 
fn: facial nerve, aica: antero-inferior cerebellar artery, V: trigeminal nerve, VI: abducens nerve, po: 
pons 
 
 
 
